Alexandra Petersson

Alexandra Petersson

Auto-generated profile, based on publicly available information

Alexandra Petersson

Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2022 in ACS Chemical Biology
Verified
Journal Article
Closed access
DPDharma Pally
Dharma Pally
MBMallar Banerjee
Mallar Banerjee
SHShahid Hussain
Shahid Hussain
RKRekha V. Kumar
Rekha V. Kumar
APAlexandra Petersson
Alexandra Petersson
RBRamray Bhat
Ramray Bhat

4 May 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Purpose: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell evolution over anatomic space in Wilms tumors. Experimental Design: We spatially mapped subclonal landscapes in a retrospective cohort of 20 Wilms tumors using high-resolution copy-number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole-mount sections (WMS) were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. Results: Compared with non-diffuse anaplasia Wilms tumors, tumors with diffuse anaplasia showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence, and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type (WT) allele in different regions. Morphologic features of anaplasia increased with copy-number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, although clonal sweeps were rare within these compartments. Conclusions: Wilms tumors with diffuse anaplasia display significantly more complex phylogenies compared with non-diffuse anaplasia Wilms tumors, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics.

15 February 2022 in Laboratory Investigation
Verified
Journal Article
Open access
CSChristina Siesing
Christina Siesing
APAlexandra Petersson
Alexandra Petersson
TUThora Ulfarsdottir
Thora Ulfarsdottir
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
BNBjörn Nodin
Björn Nodin
KJKarin Jirström
Karin Jirström
In a non-negligible number of patients with metastatic colorectal cancer (mCRC), the peritoneum is the predominant site of dissemination. Cure can be achieved by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), but this procedure is associated with long-term morbidity and high relapse rates. Thus, there is a pressing need for improved therapeutic strategies and complementary biomarkers. The present study explored the molecular heterogeneity in mCRC with peritoneal carcinomatosis (PC), and the potential clinical implications thereof. Multi-region immunohistochemical profiling and deep targeted DNA-sequencing was performed on chemotherapy-naïve tumours from seven patients with synchronous colorectal PC who underwent CRS and HIPEC. In total, 88 samples (5-19 per patient) were analysed, representing primary tumour, lymph node metastases, tumour deposits, PC and liver metastases. Expression of special AT-rich sequence-binding protein 2 (SATB2), a marker of colorectal lineage, was lacking in the majority of cases, and a conspicuous intra-patient heterogeneity was denoted for expression of the proposed prognostic and predictive biomarker RNA-binding motif protein 3 (RBM3). Loss of mismatch repair proteins MLH1 and PSM2, observed in one case, was concordant with microsatellite instability and the highest tumour mutational burden. When present in a patient, mutations in key CRC driver genes, i.e., KRAS, APC and TP53, were homogenously distributed across all samples, while less common mutations were more heterogenous. On the same note, copy number variations showed intra-patient as well inter-patient heterogeneity. In two out of seven cases, hierarchical clustering revealed that samples from the PC and lymph node metastases were more similar to each other than to the primary tumour. In summary, these findings should encourage additional studies addressing the potential distinctiveness of mCRC with PC, which might pave the way for improved personalized treatment of these patients.

11 February 2022 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
APAlexandra Petersson
Alexandra Petersson
NANatalie Andersson
Natalie Andersson
SHSofie Olsson Hau
Sofie Olsson Hau
JEJakob Eberhard
Jakob Eberhard
JKJenny Karlsson
Jenny Karlsson
KJKarin Jirström
Karin Jirström
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal disease. The only option for curative treatment is resection of the tumor followed by standard adjuvant chemotherapy. Yet, early relapse due to chemoresistance is almost inevitable. Herein, we delineated the genetic intratumor heterogeneity in resected PDAC, with the aim to identify evolutionary patterns that may be associated with overall survival (OS) following treatment with curative intent. Potential relationships with the adjacent immune microenvironment were also examined. The genetic and immune landscapes of the regional tumor space were analyzed in nine patients with resected PDAC. Targeted deep sequencing and genome wide SNP array were followed by clonal deconvolution and phylogenetic analysis. A mathematical complexity score was developed to calculate the network extent of each phylogeny. Spatial variation in abundancy and tumor nest infiltration of immune cells was analyzed by double IHC staining. Copy-number heterogeneity was denoted as the major contributing factor to the branching architectures of the produced phylogenetic trees. Increased tree complexity was significantly inversely associated with OS, and larger regional maximum aberrations (higher treetops) were associated with increased PD-L1 expression on tumor cells. Contrastingly, an FREM1 gene amplification, found in one patient, coincided with a particularly vigorous immune response. Findings from this limited case series suggest that complex evolutionary patterns may be associated with a shorter survival in surgically treated patients with PDAC. Some hypothesis-generating associations with the surrounding immune microenvironment were also detected. Implications: Evolutionary copy-number patterns may be associated with survival in patients with resected PDAC.

25 November 2025
Verified
Other
Open access
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Supplementary Table 2. Representativeness of study participants. Details on how the patients with Wilms tumor in the present study compare to the general population of patients diagnosed with with Wilms tumor.

25 November 2025
Verified
Other
Open access
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Supplementary Figure 1 Geographic overview of histological and genetic features.